Extracorporeal Treatment of Salicylate or Acetaminophen Poisoning—Is There a Role?

James F. Winchester, Michael C. Gelfand, Michael Helliwell, John Allister Vale, Roy Goulding, George E. Schreiner

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Abstract

Hemodialysis or sorbent hemoperfusion has been used in the management of clinical overdose of salicylates or acetaminophen. Hemodialysis offers considerable benefit in severe salicylate poisoning and is preferred to hemoperfusion or peritoneal dialysis, since it more rapidly corrects acid-base and electrolyte abnormalities than does hemoperfusion, and since it is clearly more efficient than is peritoneal dialysis for the removal of salicylates. Charcoal hemoperfusion in animal studies and hemodialysis in man have been shown to accelerate acetaminophen elimination from the body. Hemodialysis and hemoperfusion are of questionable benefit in clinical acetaminophen overdose. However, our clinical experience to date with charcoal hemoperfusion in “late” acetaminophen overdose has been associated with a less notable increase in liver enzyme concentrations in comparison with results of retrospective studies of series of patients treated or not treated with sulfhydryl donors.

Original languageEnglish
Pages (from-to)370-374
Number of pages5
JournalArchives of Internal Medicine
Volume141
Issue number3
DOIs
StatePublished - 23 Feb 1981
Externally publishedYes

Fingerprint

Dive into the research topics of 'Extracorporeal Treatment of Salicylate or Acetaminophen Poisoning—Is There a Role?'. Together they form a unique fingerprint.

Cite this